• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

国际肝癌流行病学:地理分布、时间趋势和未来预测。

International epidemiology of liver cancer: geographical distribution, secular trends and predicting the future.

机构信息

Department of Epidemiology and Biostatistics, School of Public Health, Isfahan University of Medical Sciences, Isfahan, Iran.

Department of Social Medicine, School of Public Health, Dezful University of Medical Sciences, Dezful, Iran.

出版信息

J Prev Med Hyg. 2020 Jul 4;61(2):E259-E289. doi: 10.15167/2421-4248/jpmh2020.61.2.1244. eCollection 2020 Jun.

DOI:10.15167/2421-4248/jpmh2020.61.2.1244
PMID:32803012
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7419131/
Abstract

BACKGROUND

Liver cancer (LC) is ranked seventh common cancer in terms of the incidence; and the fourth in terms of the mortality of cancer in the world. The aim of this study was to investigate the international distribution of the incidence and mortality of LC in 2018 based on various socio-economic and political divisions in the world.

MATERIAL AND METHODS

This study was conducted through the use of the incidence and mortality cancer data from GLOBOCAN Project in 2018. The Age-Standardized Incidence Rate (ASIR) and Age Standardized Mortality Rate (ASMR) of LC were expressed per 100,000 people. In the current report, we used Pearson correlation method to assess the correlation between ASIR and ASMR. Statistical significance was considered to be P < 0.05.

RESULTS

The highest ASIR and ASMR of LC occurred in Asia (ASIR = 11.4 and ASMR = 10.5), and Western Pacific Region of the World Health Organization (ASIR = 17.4 and ASMR = 15.8), and those regions with income level equal to upper middle income (ASIR = 13.4 and ASMR = 6.6). Furthermore, the lowest ASIR and ASMR of LC occurred in in Latin America and Caribbean (ASIR = 5) and Europe (ASMR = 4.4), the South-East Asia region (ASIR = 4.5 and ASMR = 4.3), and regions with Low middle income (ASIR = 5.7) and regions with high income (ASMR = 2.7).

CONCLUSIONS

LC is one of the most important cancer forms in the world in terms of incidence and mortality. It is important to prevent exposure to known risk factors for LC by increasing the level of knowledge and attitudes of the community and prevent of morbidity and mortality of the population with early diagnosis and treatment of patients.

摘要

背景

肝癌(LC)是全球发病率排名第七的常见癌症,死亡率排名第四。本研究旨在基于全球各种社会经济和政治划分,调查 2018 年 LC 的发病率和死亡率的国际分布。

材料与方法

本研究通过使用 GLOBOCAN 项目 2018 年的癌症发病率和死亡率数据进行。LC 的年龄标准化发病率(ASIR)和年龄标准化死亡率(ASMR)表示为每 10 万人中的人数。在本报告中,我们使用皮尔逊相关方法评估 ASIR 和 ASMR 之间的相关性。统计显著性被认为是 P < 0.05。

结果

LC 的最高 ASIR 和 ASMR 发生在亚洲(ASIR = 11.4 和 ASMR = 10.5)和世界卫生组织西太平洋地区(ASIR = 17.4 和 ASMR = 15.8),以及收入水平相当于中上收入的地区(ASIR = 13.4 和 ASMR = 6.6)。此外,LC 的最低 ASIR 和 ASMR 发生在拉丁美洲和加勒比地区(ASIR = 5)和欧洲(ASMR = 4.4)、东南亚地区(ASIR = 4.5 和 ASMR = 4.3)以及中低收入地区(ASIR = 5.7)和高收入地区(ASMR = 2.7)。

结论

LC 是全球发病率和死亡率最高的癌症之一。通过提高社区的知识水平和态度,预防已知的 LC 危险因素的暴露,以及通过早期诊断和治疗患者来预防发病率和死亡率,对于预防 LC 非常重要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d9e/7419131/707c04b76dc7/jpmh-2020-02-e259-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d9e/7419131/ca067e4e0024/jpmh-2020-02-e259-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d9e/7419131/720232ceac5e/jpmh-2020-02-e259-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d9e/7419131/9f893caa8d2a/jpmh-2020-02-e259-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d9e/7419131/3ac3b8617398/jpmh-2020-02-e259-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d9e/7419131/707c04b76dc7/jpmh-2020-02-e259-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d9e/7419131/ca067e4e0024/jpmh-2020-02-e259-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d9e/7419131/720232ceac5e/jpmh-2020-02-e259-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d9e/7419131/9f893caa8d2a/jpmh-2020-02-e259-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d9e/7419131/3ac3b8617398/jpmh-2020-02-e259-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d9e/7419131/707c04b76dc7/jpmh-2020-02-e259-g005.jpg

相似文献

1
International epidemiology of liver cancer: geographical distribution, secular trends and predicting the future.国际肝癌流行病学:地理分布、时间趋势和未来预测。
J Prev Med Hyg. 2020 Jul 4;61(2):E259-E289. doi: 10.15167/2421-4248/jpmh2020.61.2.1244. eCollection 2020 Jun.
2
[Global liver cancer incidence and mortality and future trends from 2000 to 2020: GLOBOCAN data analysis].[2000年至2020年全球肝癌发病率、死亡率及未来趋势:全球癌症负担数据(GLOBOCAN)分析]
Zhonghua Gan Zang Bing Za Zhi. 2023 Mar 20;31(3):271-280. doi: 10.3760/cma.j.cn501113-20221127-00579.
3
[Prevalence of colorectal cancer in 2020: a comparative analysis between China and the world].[2020年结直肠癌患病率:中国与世界的比较分析]
Zhonghua Zhong Liu Za Zhi. 2023 Mar 23;45(3):221-229. doi: 10.3760/cma.j.cn112152-20221008-00682.
4
Trends in gastric cancer incidence and mortality in Asia and association analysis with human development index, 1990-2019.亚洲地区胃癌发病率和死亡率的趋势及其与人类发展指数的关联分析,1990-2019 年。
Cancer Epidemiol. 2024 Feb;88:102517. doi: 10.1016/j.canep.2023.102517. Epub 2023 Dec 22.
5
Global trends in testicular cancer incidence and mortality.全球睾丸癌发病率和死亡率趋势。
Eur Urol. 2011 Aug;60(2):374-9. doi: 10.1016/j.eururo.2011.05.004. Epub 2011 May 17.
6
Global trends in the incidence and mortality of esophageal cancer from 1990 to 2017.全球 1990 年至 2017 年食管癌发病率和死亡率的变化趋势。
Cancer Med. 2020 Sep;9(18):6875-6887. doi: 10.1002/cam4.3338. Epub 2020 Aug 4.
7
Oral Cancer Incidence, Mortality, and Mortality-to-Incidence Ratio Are Associated with Human Development Index in China, 1990-2019.中国 1990-2019 年口腔癌发病率、死亡率和死亡率与发病率比与人类发展指数相关。
Biomed Res Int. 2022 Jun 28;2022:6457840. doi: 10.1155/2022/6457840. eCollection 2022.
8
[Global incidence and mortality of renal cell carcinoma in 2020].[2020年肾细胞癌的全球发病率和死亡率]
Zhonghua Liu Xing Bing Xue Za Zhi. 2023 Apr 10;44(4):575-580. doi: 10.3760/cma.j.cn112338-20220624-00558.
9
Patterns and trends of HPV-related cancers other than cervix in South Africa from 1994-2013.1994-2013 年南非除宫颈癌以外的 HPV 相关癌症的模式和趋势。
Cancer Epidemiol. 2019 Feb;58:121-129. doi: 10.1016/j.canep.2018.12.004. Epub 2018 Dec 15.
10
Secular trends of salted fish consumption and nasopharyngeal carcinoma: a multi-jurisdiction ecological study in 8 regions from 3 continents.食用咸鱼与鼻咽癌的流行趋势:来自三大洲 8 个地区的多司法管辖区生态学研究。
BMC Cancer. 2013 Jun 19;13:298. doi: 10.1186/1471-2407-13-298.

引用本文的文献

1
The prognostic value of mitogen-activated protein kinase kinase in liver hepatocellular carcinoma by bioinformatics.通过生物信息学分析丝裂原活化蛋白激酶激酶在肝细胞癌中的预后价值
Medicine (Baltimore). 2025 Jun 27;104(26):e42933. doi: 10.1097/MD.0000000000042933.
2
Regional Variations in the Prevalence of Risk Factors and Non-Communicable Diseases in Papua New Guinea: A Scoping Review.巴布亚新几内亚危险因素和非传染性疾病患病率的区域差异:一项范围综述
Int J Environ Res Public Health. 2025 Jan 14;22(1):102. doi: 10.3390/ijerph22010102.
3
The occurrence and human health risk assessment of total and aflatoxin B in selected food commodities in Bhutan.

本文引用的文献

1
Socioeconomic inequalities in cancer incidence in Europe: a comprehensive review of population-based epidemiological studies.欧洲癌症发病率的社会经济不平等:基于人群的流行病学研究综合评价。
Radiol Oncol. 2020 Feb 19;54(1):1-13. doi: 10.2478/raon-2020-0008.
2
International trends in hepatocellular carcinoma incidence, 1978-2012.国际 1978-2012 年肝细胞癌发病率趋势。
Int J Cancer. 2020 Jul 15;147(2):317-330. doi: 10.1002/ijc.32723. Epub 2019 Nov 5.
3
Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2017: A Systematic Analysis for the Global Burden of Disease Study.
不丹部分食品中总黄曲霉毒素和黄曲霉毒素 B 的发生及其对人类健康的风险评估。
Sci Rep. 2024 Jul 15;14(1):16258. doi: 10.1038/s41598-024-63677-6.
4
Investigating the Relationship between Cadmium Exposure and the Risk of Prostate Cancer: A Systematic Review and Dose-Response Meta-Analysis.镉暴露与前列腺癌风险之间的关系研究:一项系统综述和剂量反应荟萃分析
Iran J Public Health. 2024 Mar;53(3):553-567. doi: 10.18502/ijph.v53i3.15136.
5
Outcomes of elective liver surgery worldwide: a global, prospective, multicenter, cross-sectional study.全球择期肝外科手术结局:一项全球性、前瞻性、多中心、横断面研究。
Int J Surg. 2023 Dec 1;109(12):3954-3966. doi: 10.1097/JS9.0000000000000711.
6
RNA m6A methylation regulators in liver cancer.肝癌中的RNA m6A甲基化调节因子
Cancer Cell Int. 2024 Jan 2;24(1):1. doi: 10.1186/s12935-023-03197-x.
7
The Effect of Monovalent Influenza Vaccine on the Risk of Hospitalization and All-Cause Mortality According to the Results of Randomized Clinical Trials: A Systematic Review and Meta-Analysis.根据随机临床试验结果评估单价流感疫苗对住院风险和全因死亡率的影响:一项系统评价和荟萃分析
Iran J Public Health. 2023 May;52(5):924-936. doi: 10.18502/ijph.v52i5.12709.
8
The Use of ctDNA in the Diagnosis and Monitoring of Hepatocellular Carcinoma-Literature Review.ctDNA 在肝细胞癌诊断和监测中的应用——文献综述。
Int J Mol Sci. 2023 May 26;24(11):9342. doi: 10.3390/ijms24119342.
9
Tumor organoid biobank-new platform for medical research.肿瘤类器官生物库——医学研究的新平台。
Sci Rep. 2023 Feb 1;13(1):1819. doi: 10.1038/s41598-023-29065-2.
10
Secular Trends of Liver Cancer Mortality and Years of Life Lost in Wuhan, China 2010-2019.2010-2019 年中国武汉地区肝癌死亡率和生命损失年数的变化趋势。
Curr Oncol. 2023 Jan 9;30(1):938-948. doi: 10.3390/curroncol30010071.
全球、区域和国家癌症发病率、死亡率、生命损失年数、失能生存年数以及 29 种癌症组别的伤残调整生命年数:1990 至 2017 年全球疾病负担研究的系统分析。
JAMA Oncol. 2019 Dec 1;5(12):1749-1768. doi: 10.1001/jamaoncol.2019.2996.
4
Cancer mortality in Europe in 2015 and an overview of trends since 1990.2015 年欧洲癌症死亡率及自 1990 年以来的趋势概述。
Ann Oncol. 2019 Aug 1;30(8):1356-1369. doi: 10.1093/annonc/mdz179.
5
The Role of Autophagy in Liver Epithelial Cells and Its Impact on Systemic Homeostasis.自噬在肝上皮细胞中的作用及其对全身稳态的影响。
Nutrients. 2019 Apr 11;11(4):827. doi: 10.3390/nu11040827.
6
Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods.估算 2018 年全球癌症发病率和死亡率:GLOBOCAN 来源和方法。
Int J Cancer. 2019 Apr 15;144(8):1941-1953. doi: 10.1002/ijc.31937. Epub 2018 Dec 6.
7
Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2016: A Systematic Analysis for the Global Burden of Disease Study.全球、区域和国家癌症发病率、死亡率、生命损失年数、失能生存年数以及 29 种癌症组别的伤残调整生命年数,1990 年至 2016 年:全球疾病负担研究的系统分析。
JAMA Oncol. 2018 Nov 1;4(11):1553-1568. doi: 10.1001/jamaoncol.2018.2706.
8
The Incidence and Mortality of Colorectal Cancer and Its Relationship With the Human Development Index in Asia.亚洲结直肠癌的发病率和死亡率及其与人类发展指数的关系。
Ann Glob Health. 2016 Sep-Oct;82(5):726-737. doi: 10.1016/j.aogh.2016.10.004.
9
Epidemiology and Inequality in the Incidence and Mortality of Nasopharynx Cancer in Asia.亚洲鼻咽癌发病率和死亡率的流行病学与不平等现象
Osong Public Health Res Perspect. 2016 Dec;7(6):360-372. doi: 10.1016/j.phrp.2016.11.002. Epub 2016 Nov 16.
10
Incidence and mortality of kidney cancers, and human development index in Asia; a matter of concern.亚洲肾癌的发病率和死亡率以及人类发展指数:一个值得关注的问题。
J Nephropathol. 2017 Jan;6(1):30-42. doi: 10.15171/jnp.2017.06. Epub 2016 Aug 7.